Join us on Thursday, 14 October 2021 at 16:00 East Africa Time for this LabCoP Extended session about screening for latent tuberculosis (TB) infection in resource-limited settings and innovative solutions to meet EndTB goals. Achieving ambitious EndTB strategy goals would not be possible without bridging gaps in the existing TB care cascade and, amongst other activities, implementing latent TB infection (LTBI) screening in high-risk groups. However, high cost and lack of infrastructure have been identified among critical barriers to implementing LTBI testing in resource-constrained settings, highlighting a need for innovative, scalable solutions.
This session will focus on the basics of LTBI, the critical importance of screening for LTBI in addition to active TB case finding, and test-and-treat strategy. Experts will discuss gaps in the current TB care cascade, consider various options for LTBI screening and highlight the benefits of the test-and-treat approach, including interferon-gamma release assays (IGRA) testing and shorter TB preventive treatment regimens recommended by the World Health Organization. Attendees will learn about the evolution of IGRA testing and new technological applications which might make it possible to screen for latent infection in a decentralised setting.
Speakers:
Giorgio Roscigno, Chairman, Next2People
Addressing gaps in current TB care cascade through the implementation of screening for LTBI in high-risk groups
Davide Manissero, Chief Medical Officer, QIAGEN
Innovative solutions for LTBI screening in decentralised settings
Register for the session here.
Zoom Details:
Meeting ID: 835 6472 0015
Passcode: 727316
